Rezolve AI has reversed course since last week's note — short interest is rebuilding modestly, the borrow market is tightening again, and Q2 results on July 30 are ten days away.
The most striking development is how quickly borrow conditions have deteriorated after appearing to normalise. Availability has fallen back to 28.7% — less than one share available for every three currently borrowed — after spending the middle of the week near 112%. That tightening happened fast: availability was above 100% as recently as July 13 and 14, then collapsed over two sessions. Cost to borrow tells a parallel story in reverse: it peaked above 200% APR in late June, fell steadily to 14.1% by July 17, but the speed of the availability decline suggests the downward pressure on borrow costs may have run its course. For context, the 52-week availability low was 0.07% on June 12, when the borrow market was essentially locked shut — today's reading is loose by comparison but has moved meaningfully in the wrong direction for anyone looking to add a short position cheaply.
Short interest has stopped falling and nudged higher. The position has grown roughly 1.7% over the week to 35.4 million shares, equivalent to 11.8% of free float — a reversal of the covering trend that dominated the previous four weeks. The month-on-month picture still shows a 27% reduction from the late-June peak near 50 million shares, so shorts have not rebuilt in any meaningful structural way. But the direction has flipped. The ORTEX short score has drifted to 75.1, down from 82 at the start of the month, reflecting the partial easing — yet the score still ranks in the 3rd percentile for its sector, meaning this stock remains among the most heavily shorted names in its peer group. Options traders are not adding much signal: the put/call ratio at 0.29 is barely a whisker above its 20-day average and near the top of its narrow 52-week band between 0.11 and 0.29, suggesting options positioning is remarkably stable and is not flagging any particular directional conviction ahead of earnings.
The broader picture on the Street remains thinly covered. Insider buying from founder and Chairman/CEO Daniel Wagner totalled over $3.2 million in early April at $4.00 per share — a price well above the current $2.31 close, which means those buys are underwater. A smaller purchase from director Stephen Perry in mid-May at $2.78 fares only slightly better. Net insider buying across the 90-day window amounts to roughly 908,000 shares at a combined value of $3.5 million — real money committed, but the positions have not paid off yet. On valuation, meaningful multiples are hard to apply: the company carries negative EBITDA and a deeply negative EV/EBITDA of around -409x, and the growth score of 90 (driven by a 1,058% year-on-year sales increase, per the recent stock-score note) sits alongside quality and value scores in the low-to-mid 20s. BlackRock added 2 million shares to reach 3.0% of the company as of April 30, and State Street and UBS both added modestly in Q1 — institutional interest is present but not yet a conviction theme.
Peer pressure adds context. Close correlated names had a rough week: REKR fell 18.5%, QBTS dropped 16.7%, and GRRR lost 32.9%. RZLV's 11% weekly decline looks contained by comparison, though SOUN held better at -5.6% and PLTR managed a 4.4% gain — a reminder that the cohort is fragmenting as investors distinguish between AI names with visible revenue traction and those still proving the model. The most recent earnings print — a 3.2% next-day gain and 9.9% five-day gain on June 26 — broke a two-event streak of muted reactions, so the market has shown it can respond positively to results. What July 30 does to the $350 million revenue guidance, which the previous note flagged as nearly double Street consensus, will determine whether this week's rebuilding short position is validated or caught offside.
The question heading into the print is whether the modest short rebuild and renewed borrow-market tightening reflect informed positioning — or simply mechanical friction in a thin lending pool for a stock with no obvious catalyst before results day.
See the live data behind this article on ORTEX.
Open RZLV on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
